The promising immunomoduator therapy

Tacrolimus 0.1% w/w OINTMENT

Successful outcomes in patients with severe immunodisorders

• Short-term treatment of moderate to severe atopic dermatitis
• Decrease the cell activity causing dermatits & psoriasis
• Helps reduce inflammatory skin reactions in moderate to severe eczema
• Provides no skin thinning unlike topical corticosteroids

Topical tacrolimus therapy, particular utility has been observed in cases of inverse psoriasis and psoriasis affecting the face, genitalia and nails.

• Atopical dermatitis
• Vitiligo
• Cutaneous lupus erythematosus
• Hand & foot eczema
• Discoid lupus erythematosus
• Lichen planus
• Allergic contact dermatitis psoriasis